FDA Inspection 964577 — Morton Grove Pharmaceuticals, Inc.
The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on February 5, 2016 in Morton Grove, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 5, 2016
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Morton Grove, IL (United States)